The immunopathogenesis of SJS involves activation of drug-specific cytotoxic CD8+ T cells and natural killer cells, leading to widespread keratinocyte apoptosis through Fas-FasL interactions, perforin/granzyme release, and granulysin secretion [6]. This evidence concerns the gene GNLY and Schwartz-Jampel syndrome.